Showing results (1691-1700 of 1,800) with videos related to

Sort By:
Pageof 180
Hepatology Communications|June 5, 2024
Partial liver resection alters the bile salt-FGF19 axis in patients with perihilar cholangiocarcinoma: Implications for liver regenerationKiran V K Koelfat, Frank G Schaap, Kim M C van Mierlo, et al.
Hepatology Communications|May 10, 2024
An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancerAndres F Espinoza, Pavan Kureti, Roma H Patel, et al.
Hepatology Communications|May 10, 2024
Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrenceArun J Sanyal, Kris V Kowdley, Nancy S Reau, et al.
Hepatology Communications|April 15, 2024
mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytesAmanda K Jones, Besnik Bajrami, Morgan K Campbell, et al.
Hepatology Communications|April 15, 2024
Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitisJunyan Lyu, Hikari Okada, Hajime Sunagozaka, et al.
Hepatology Communications|April 26, 2024
A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipidsLeonida Hehl, Kate T Creasy, Cecilia Vitali, et al.
Hepatology Communications|January 16, 2026
Effect of glucagon-like peptide-1 receptor agonists on histologic MASH: A meta-analysis of randomized controlled trialsNoppachai Siranart, Christopher C Thompson, Pichamol Jirapinyo
Hepatology Communications|January 16, 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytesLaura Valestrand, Kathrine S Nordhus, Thierry Claudel, et al.
Hepatology Communications|January 29, 2026
MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic diseaseGiovanni Inzalaco, Sara Gargiulo, Denise Bonente, et al.
Pageof 180